References and Notes
<A NAME="RS02306ST-1">1</A>
Finkelstein R.
Baughman RW.
Steele FR.
Mol. Ther.
2001,
3:
3
<A NAME="RS02306ST-2">2</A>
Kayser O.
Kiderlen AF.
Pharm. Biotechnol.
2004,
249
<A NAME="RS02306ST-3">3</A>
Ozawa K.
Uirusu
2004,
54:
49
<A NAME="RS02306ST-4">4</A>
McGarrity GJ.
Animal Cell Culture Techniques
Clynes M.
Springer;
Berlin:
1998.
p.600-612
<A NAME="RS02306ST-5">5</A>
Amalfitano A.
Parks RJ.
Curr. Gene Ther.
2002,
2:
111
<A NAME="RS02306ST-6">6</A>
Hauser H.
Spitzer D.
Verhoeyen E.
Unsinger J.
Wirth D.
Cells Tissues Organs
2000,
167:
75
<A NAME="RS02306ST-7">7</A>
Suzuki M.
Matsuse T.
Isigatsubo Y.
Curr. Mol. Med.
2001,
1:
67
<A NAME="RS02306ST-8">8</A>
Friedmann T.
Sci. Am.
1997,
276:
96
<A NAME="RS02306ST-9">9</A>
Parker AL.
J. Drug Targeting
2005,
13:
39
<A NAME="RS02306ST-10">10</A>
Miller AD.
Medical and Biotechnology Applications, In Microspheres, Microcapsules & Liposomes
Vol. 2:
Citus Books;
London:
1999.
p.545
<A NAME="RS02306ST-11">11</A>
Bennett MJ.
Aberle AM.
Balasubramanian JG.
Malone JG.
Nantz MH.
Malone RW.
J. Liposome Res.
1996,
6:
545
<A NAME="RS02306ST-12">12</A>
Felgner PL.
Tsai YJ.
Felgner JH.
Handbook of Nonmedical Applications of Liposomes
Vol. 4:
CRC Press;
Boca Raton:
1996.
p.43-56
<A NAME="RS02306ST-13">13</A>
Zabner J.
Adv. Drug Deliv. Rev.
1997,
27:
17
<A NAME="RS02306ST-14">14</A>
Miller AD.
Angew. Chem. Int. Ed.
1998,
37:
1769
<A NAME="RS02306ST-15">15</A>
Felgner PL.
Gadek TR.
Holm M.
Roman R.
Chan HW.
Wenz M.
Northrop JP.
Ringold GM.
Danielsen M.
Proc. Natl. Acad. Sci. U.S.A.
1987,
84:
7413
<A NAME="RS02306ST-16">16</A>
Remy JS.
Sirlin C.
Vierling P.
Behr JP.
Bioconjugate Chem.
1994,
5:
647
<A NAME="RS02306ST-17">17</A>
Selected Data for Compound 4.
1H NMR (400 MHz, CDCl3): δ = 5.43 (m, 4 H CHCH), 4.11-3.89 (m, 7 H, OCH, OCH2), 3.59 (s, 6 H, 2 CH3), 3.51 (m, 6 H, NCH2CHO, NCH2), 2.00 (m, 8 H, CH2CHCH), 1.46-1.20 (m, 48 H, CH2), 0.93 (t, 6 H, J = 5.2 Hz, CH3). 13C NMR (100 MHz, CDCl3): δ = 130.9, 129.7 (CHCH), 74.6 (CHO), 72.1, 69.5, 68.2 (CH2O), 65.8, 62.4 (CH2NCH2), 53.9, 53.5 (CH3), 43.1 (CH2NCO), 32.8-22.8 (CH2CH2), 14.3 (CH3). MALDI-MS: m/z = 664.6765 [M + H+].
Selected Data for Compound 10.
1H NMR (400 MHz, CD3OD): δ = 5.38 (m, 4 H, CHCH), 3.92-3.02 (m, 30 H, CHCONH, NCH3, CH2O, CHO, CH2N), 2.06-1.20 (m, 70 H, CH2, CH3, CH2CH2NH2, CH2CH2NH, CH2CHCO). 13C NMR (100 MHz, CDCl3): δ = 155.2 (CO), 130.1, 129.9 (CHCH), 80.6, 79.8, 78.9, 78.5 [C(CH3)3], 72.9 (CHO), 72.8, 71.2 (CH2NCH2), 68.7, 68.0 (OCH2), 60.9 (NCHCONH), 53.9, 52.8 (NCH3), 52.1 (CONHCH2CH2), 47.8-38.2 (CH2NCO), 32.1-22.1 (CH2CH2, CH2CH2NHCO, CH2CHCO), 14.3 (CH3). MALDI-MS: m/z = 1072.1552 [M + H+].